[go: up one dir, main page]

NO20055889L - 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser - Google Patents

2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser

Info

Publication number
NO20055889L
NO20055889L NO20055889A NO20055889A NO20055889L NO 20055889 L NO20055889 L NO 20055889L NO 20055889 A NO20055889 A NO 20055889A NO 20055889 A NO20055889 A NO 20055889A NO 20055889 L NO20055889 L NO 20055889L
Authority
NO
Norway
Prior art keywords
ethoxy
treatment
acid derivatives
phenylpropanoic acid
fat disorders
Prior art date
Application number
NO20055889A
Other languages
English (en)
Inventor
Eva-Lotte Lindstedt Alstermark
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20055889L publication Critical patent/NO20055889L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelse med formel I hvor T representerer O, S eller NR og hvor R representerer H, en C1-6alkylgruppe eller en fenyl-C1-6alkylgruppe, og farmasøytisk akseptable salter derav, fremgangsmåter for fremstilling av slike forbindelser, deres nytte ved behandling av jo kliniske tilstander, inkludert lipidforstyrrelser (dyslipidemier) som eventuelt kan være forbundet med insulinresistens, metoder for deres terapeutiske anvendelse og farmasøytiske preparater som inneholder dem.
NO20055889A 2003-06-18 2005-12-12 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser NO20055889L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314078.7A GB0314078D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/GB2004/002619 WO2004113276A1 (en) 2003-06-18 2004-06-16 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders

Publications (1)

Publication Number Publication Date
NO20055889L true NO20055889L (no) 2006-01-12

Family

ID=27636749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055889A NO20055889L (no) 2003-06-18 2005-12-12 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser

Country Status (23)

Country Link
US (1) US7309720B2 (no)
EP (1) EP1638926A1 (no)
JP (1) JP2006527752A (no)
KR (1) KR20060030043A (no)
CN (1) CN1835916A (no)
AR (1) AR044827A1 (no)
AU (1) AU2004249494B2 (no)
BR (1) BRPI0411579A (no)
CA (1) CA2529253A1 (no)
CO (1) CO5650239A2 (no)
GB (1) GB0314078D0 (no)
IL (1) IL172377A0 (no)
IS (1) IS8225A (no)
MX (1) MXPA05013717A (no)
MY (1) MY137679A (no)
NO (1) NO20055889L (no)
RU (1) RU2005141067A (no)
SA (1) SA04250194B1 (no)
TW (1) TW200502202A (no)
UA (1) UA81810C2 (no)
UY (1) UY28368A1 (no)
WO (1) WO2004113276A1 (no)
ZA (1) ZA200510254B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711621B2 (ja) * 2001-06-12 2011-06-29 ウェルスタット セラピューティクス コーポレイション 代謝障害治療用化合物
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
TWI282784B (en) 2002-06-20 2007-06-21 Astrazeneca Ab Therapeutic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
IS8225A (is) 2006-01-10
AU2004249494B2 (en) 2008-03-20
UA81810C2 (uk) 2008-02-11
CO5650239A2 (es) 2006-06-30
ZA200510254B (en) 2007-04-25
BRPI0411579A (pt) 2006-08-08
AR044827A1 (es) 2005-10-05
CN1835916A (zh) 2006-09-20
EP1638926A1 (en) 2006-03-29
UY28368A1 (es) 2005-01-31
RU2005141067A (ru) 2006-07-27
SA04250194B1 (ar) 2008-06-02
AU2004249494A1 (en) 2004-12-29
JP2006527752A (ja) 2006-12-07
IL172377A0 (en) 2009-02-11
MXPA05013717A (es) 2006-03-08
US7309720B2 (en) 2007-12-18
KR20060030043A (ko) 2006-04-07
TW200502202A (en) 2005-01-16
GB0314078D0 (en) 2003-07-23
MY137679A (en) 2009-02-27
WO2004113276A1 (en) 2004-12-29
CA2529253A1 (en) 2004-12-29
US20060178432A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
NO20081367L (no) Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20072259L (no) Heteroaryltiazoler og deres anvendelse som P13K-inhibitorer
WO2004072031A8 (en) Phenylacetamides and their use as glucokinase modulators
NO20072784L (no) Pyridenkarboksamidderivater for anvendelse som anticancer midler
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
NO20070576L (no) Nye hydantionderivater for behandling av obstruktive luftveissykdommer.
NO20066055L (no) Pyridinderivater
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
WO2005005414A3 (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO20065260L (no) Tri(cyklo)substituerte amidforbindelser
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20081369L (no) Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20053748L (no) Pyrrolopyridazinderivater.
WO2006030439A3 (en) Compositions and methods for inducing hair growth
NO20070570L (no) Forbindelser.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение
NO20073113L (no) Indenylderivater og anvendelse derav for behandling av neurologiske lidelser
NO20080372L (no) Pyrazolderivater som teraputiske midler
NO20070067L (no) Pyrrolopyridinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application